dvm360

First treatment for delaying canine congestive heart failure receives FDA approval

The approval broadens Vetmedin’s label, which already covers management of mild to severe congestive heart failure in dogs with clinical myxomatous mitral valve disease or dilated cardiomyopathy.
Medindia

FDA Approves First Preventive Heart Failure Drug for Dogs

Discover how the FDA's approval of Vetmedin, the first drug to delay congestive heart failure in dogs, is transforming canine ...
Business Insider

AKC Canine Health Foundation Celebrates $2.6 million in New Research Funding in 2023

RALEIGH, N.C., Dec. 27, 2023 /PRNewswire/ -- The AKC Canine Health Foundation (CHF), a non-profit organization dedicated to advancing the health of all dogs, celebrates $2.6 million awarded for canine ...

US FDA approves first drug to delay heart failure in dogs

Jan 19 (Reuters) - Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had ...

FDA approves first drug to delay the onset of congestive heart failure in dogs

The MarketWatch News Department was not involved in the creation of this content.-- Heart disease affects approximately 10 percent of dogs in their lifetime1 -- VETMEDIN(R) (pimob ...
Yahoo Finance

FDA approves first drug to delay the onset of congestive heart failure in dogs

DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...
Morningstar

FDA approves first drug to delay the onset of congestive heart failure in dogs

Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...